Surveillance of drug resistance of Acinetobacter spp. In lower respiratory tract samples

Hai-qing Chu,Hui-ping Li,Guo-jun He,Jie-ming Qu
DOI: https://doi.org/10.3969/j.issn.1001-9057.1999.06.018
2000-01-01
Abstract:Objective: To study the drug resistance of Acinetobacter spp. of lower respiratory tract so as to rationalize treatment. Method: (1) Sputum specimens of lower respiratory tract from patients in our hospital were cultured for bacteria and identification between Jan. 1995 to Dec. 1998; (2) Drug susceptibility was determined by K-B methods. Result: (1) Four thousand five hundred and eighty-one strains of various of bacteria were isolated from specimens of lower respiratory tract. 607 strains (13.3%) of which were Acinetobacter spp. (ranking the second). 436 strains (71.8%) of Acinetobacter spp. were Acinetobacter baumanii; (2) By determining the drug susceptibility of Acinetobacter spp. to 13 antibiotics, it was found that the resistant rates of bacterium to imipenem, amikacin, ampicilin-sulbactam were 2.4%, 8.1% and 10.0%, respectively. The resistant rates to ceftazidime, piperacillin, ciprofloxacin, gentamicin were 11.2%, 16.1%, 16.4% and 16.7%, respectively. The resistant rates to other antibiotics were also high, partly higher than 90%. Conclusion: Attention should be paid to the high isolating rate of Acinetobacter spp. in the lower respiratory tract samples and the high drug resistance, and the role of this bacterium in the lower respiratory tract needs to be studied.
What problem does this paper attempt to address?